QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, November 4, 2009, 29(44):14050-14056; doi:10.1523/JNEUROSCI.4654-09.2009

This Article Full Text Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Google Scholar Articles by McCann, U. D. Articles by Ricaurte, G. A. PubMed PubMed Citation Articles by McCann, U. D. Articles by Ricaurte, G. A.

 Previous Article

Behavioral/Systems/Cognitive
Sleep Deprivation Differentially Impairs Cognitive Performance in Abstinent Methylenedioxymethamphetamine ("Ecstasy") Users

Una D. McCann,¹ Michael J. Wilson,² Francis P. Sgambati,¹ and George A. Ricaurte²

¹Departments of Psychiatry and ²Neurology, The Johns Hopkins School of Medicine, Baltimore, Maryland 21224

Correspondence should be addressed to Dr. Una D. McCann, Department of Psychiatry, The Johns Hopkins School of Medicine, 5501 Hopkins Bayview Circle, Room 5B71c, Baltimore, MD 21224. Email: umccann{at}jhmi.edu

Methylenedioxymethamphetamine (MDMA; "Ecstasy") is a popular recreational drug and brain serotonin (5-HT) neurotoxin. Neuroimaging data indicate that some human MDMA users develop persistent deficits in brain 5-HT neuronal markers. Although the consequences of MDMA-induced 5-HT neurotoxicity are not fully understood, abstinent MDMA users have been found to have subtle cognitive deficits and altered sleep architecture. The present study sought to test the hypothesis that sleep disturbance plays a role in cognitive deficits in MDMA users. Nineteen abstinent MDMA users and 21 control subjects participated in a 5 d inpatient study in a clinical research unit. Baseline sleep quality was measured using the Pittsburgh Sleep Quality Inventory. Cognitive performance was tested three times daily using a computerized cognitive battery. On the third day of admission, subjects began a 40 h sleep deprivation period and continued cognitive testing using the same daily schedule. At baseline, MDMA users performed less accurately than controls on a task of working memory and more impulsively on four of the seven computerized tests. During sleep deprivation, MDMA users, but not controls, became increasingly impulsive, performing more rapidly at the expense of accuracy on tasks of working and short-term memory. Tests of mediation implicated baseline sleep disturbance in the cognitive decline seen during sleep deprivation. These findings are the first to demonstrate that memory problems in MDMA users may be related, at least in part, to sleep disturbance and suggest that cognitive deficits in MDMA users may become more prominent in situations associated with sleep deprivation.

---

Received Sept. 18, 2009; revised Oct. 1, 2009; accepted Oct. 5, 2009.

Correspondence should be addressed to Dr. Una D. McCann, Department of Psychiatry, The Johns Hopkins School of Medicine, 5501 Hopkins Bayview Circle, Room 5B71c, Baltimore, MD 21224. Email: umccann{at}jhmi.edu

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help